Neuro–visceral immunometabolic network phenotyping via baseline whole-body [¹⁸F]FDG PET/CT underlying pathologic response to neoadjuvant immunochemotherapy in resectable NSCLC
本文未提供摘要,请点击“查看全文”查看完整内容。